Answers are grounded in this paper and cite their sources.
In the last 50 years there has been significant improvement in survival for children with cancer, achieved by the implementation of cooperative clinical research trials that found an opportunity to standardize and to control treatment of childhood cancer. Combined modalities in treatment approaches, intensification of chemotherapy regimens for high-risk disease allow to reach 70 % survival rate of all cases. Yet there is still a need to improve outcomes and decrease side effects of anticancer treatment in groups of unfavorable prognosis. The most promising point is personification of treatment with a special focus on targeted drug therapies and immunotherapy. We reviewed recent international advances and unique options in precision medicine for pediatric cancers.
No takes yet. Share an insight, caveat, or question.
Dinikina et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: